Novo Soars on Obesity Pill Approval; Huntington Ingalls Rallies; Warner Bros
On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. - Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.